Uterotrophic assay, Hershberger assay, and subacute oral toxicity study of 4,4´-[1-[4-[1-(4-hydroxyphenyl)-1-methylethyl]phenyl]ethylidene]bis[phenol] based on the OECD draft protocols

[1]  K. Yamasaki,et al.  Subacute oral toxicity study of di(2-ethylhexyl)adipate based on the draft protocol for the “Enhanced OECD Test Guideline no. 407” , 2006, Archives of Toxicology.

[2]  T. Seki,et al.  Evaluation for reliability and feasibility of the draft protocol for the enhanced rat 28-day subacute study (OECD Guideline 407) using androgen antagonist flutamide. , 2004, Toxicology.

[3]  B. van Ravenzwaay,et al.  Detection of endocrine-modulating effects of the antithyroid acting drug 6-propyl-2-thiouracil in rats, based on the "Enhanced OECD Test Guideline 407". , 2003, Regulatory toxicology and pharmacology : RTP.

[4]  Yoshikuni Yakabe,et al.  Comparative study of the uterotrophic potency of 14 chemicals in a uterotrophic assay and their receptor-binding affinity. , 2003, Toxicology letters.

[5]  Remi Bars,et al.  17alpha-methyltestosterone: 28-day oral toxicity study in the rat based on the "Enhanced OECD Test Guideline 407" to detect endocrine effects. , 2003, Toxicology.

[6]  Sung-Dae Cho,et al.  Pre-validation study for OECD enhanced test guideline 407 protocol by gavage for 4 weeks using propylthiouracil and tamoxifen. , 2003, Toxicology letters.

[7]  R. Bars,et al.  Tamoxifen: 28-day oral toxicity study in the rat based on the Enhanced OECD Test Guideline 407 to detect endocrine effects , 2003, Archives of Toxicology.

[8]  M. Takatsuki,et al.  Comparison of toxicity studies based on the draft protocol for the 'Enhanced OECD Test Guideline no. 407' and the research protocol of 'Pubertal Development and Thyroid Function in Immature Male Rats' with 6-n-propyl-2-thiouracil , 2002, Archives of Toxicology.

[9]  Shuji Noda,et al.  Subacute oral toxicity study of ethynylestradiol and bisphenol A, based on the draft protocol for the 'Enhanced OECD Test Guideline no. 407' , 2002, Archives of Toxicology.

[10]  G. Woo,et al.  A repeated 28-day oral dose toxicity study of nonylphenol in rats, based on the ‘Enhanced OECD Test Guideline 407’ for screening of endocrine-disrupting chemicals , 2001, Archives of Toxicology.

[11]  A. Nishikawa,et al.  P10-09 A Repeated 28 Days Oral Dose Toxicity Study of Methoxychlor in Rats, Based on the 'Enhanced OECD Test Guideline 407' for Screening Endocrine-disrupting Chemicals. , 2001 .

[12]  P. Andrews,et al.  Feasibility and potential gains of enhancing the subacute rat study protocol (OECD test guideline no. 407) by additional parameters selected to determine endocrine modulation. A pre-validation study to determine endocrine-mediated effects of the antiandrogenic drug flutamide , 2001, Archives of Toxicology.

[13]  K. Toyoda,et al.  Repeated dose (28 days) oral toxicity study of flutamide in rats, based on the draft protocol for the `Enhanced OECD Test Guideline 407' for screening for endocrine-disrupting chemicals , 2000, Archives of Toxicology.

[14]  Jae-Ho Shin,et al.  Repeated 28-day oral toxicity study of vinclozolin in rats based on the draft protocol for the “Enhanced OECD Test Guideline No. 407” to detect endocrine effects , 2006, Archives of Toxicology.

[15]  K. Yamasaki,et al.  Subacute oral toxicity study of diethylphthalate based on the draft protocol for “Enhanced OECD Test Guideline no. 407” , 2005, Archives of Toxicology.

[16]  A. Nishikawa,et al.  A repeated 28-day oral dose toxicity study of genistein in rats, based on the 'Enhanced OECD Test Guideline 407' for screening endocrine-disrupting chemicals , 2002, Archives of Toxicology.

[17]  T. Imazawa,et al.  A repeated 28-day oral dose toxicity study of 17α-methyltestosterone in rats, based on the 'Enhanced OECD Test Guideline 407' for screening the endocrine-disrupting chemicals , 2001, Archives of Toxicology.